Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
Influenza A virus (IAV) is the causative agent of flu disease that results in annual epidemics and occasional pandemics. IAV alters several signaling pathways of the cellular host response in order to promote its replication. Therefore, our group investigates different host cell pathways modified in IAV infection as promising targets for long-lasting therapeutic approaches. Here, we show that c-Jun NH2-terminal kinase (JNK)-interacting protein (JIP) 4 is dynamically phosphorylated in IAV infection. Lack of JIP4 resulted in higher virus titers with significant differences in viral protein and mRNA accumulation as early as within the first replication cycle. In accordance, decreased IAV titers and protein accumulation was observed during overexpression of JIP4. Strikingly, the anti-viral function of JIP4 does neither originate from a modulation of JNK or p38 MAPK pathways, nor from altered expression of interferons or interferon-stimulated genes, but rather from a direct reduction of viral polymerase activity. Furthermore, interference of JIP4 with IAV replication is linked to phosphorylation of the serine at position 730, that is sufficient to impede with the viral polymerase and is mediated by the Raf/MEK/ERK pathway. Collectively, we provide evidence that JIP4, a host protein modulated in IAV infection, exhibits anti-viral properties that are dynamically controlled by its phosphorylation at S730.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (32)
- Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis via crossref
- doi:10.1093/infdis/jiq012 via crossref
- doi:10.1016/j.antiviral.2020.104806 via crossref
- doi:10.1515/hsz-2011-0270 via crossref
- doi:10.1074/jbc.m009902200 via crossref
- doi:10.1074/jbc.m113.469239 via crossref
- doi:10.1128/mcb.25.7.2733-2743.2005 via crossref
- doi:10.1016/j.cellsig.2015.08.009 via crossref
- doi:10.1083/jcb.201506002 via crossref
- doi:10.1038/ncomms1804 via crossref
- doi:10.1074/mcp.o114.045302 via crossref
- doi:10.1016/j.jchromb.2009.02.036 via crossref
- doi:10.1093/infdis/jir716 via crossref
- doi:10.1016/j.jviromet.2010.12.014 via crossref
- doi:10.1016/j.virusres.2015.02.003 via crossref
- doi:10.1128/jvi.01372-19 via crossref
- doi:10.1126/science.1257037 via crossref
- doi:10.4149/av_2013_02_113 via crossref
- doi:10.1074/mcp.m900285-mcp200 via crossref
- doi:10.3389/fonc.2015.00095 via crossref
- doi:10.1128/mcb.19.10.7245 via crossref
- doi:10.1111/cmi.12721 via crossref
- doi:10.1111/j.1462-5822.2010.01436.x via crossref
- doi:10.1128/jvi.76.21.11166-11171.2002 via crossref
- doi:10.3389/fmicb.2017.02426 via crossref
- doi:10.1093/jac/dkp161 via crossref
- doi:10.1016/j.antiviral.2018.07.006 via crossref
- doi:10.1111/j.1462-5822.2010.01556.x via crossref
- doi:10.1073/pnas.2002828117 via crossref
- doi:10.1111/j.1462-5822.2007.00902.x via crossref
- doi:10.1371/journal.pone.0119115 via crossref
- doi:10.1074/jbc.m403258200 via crossref
Source provenance
- crossref
- last seen: 2026-06-16T06:25:26.297975+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-ND-4.0